Seasonal Influenza Vaccine Effectiveness, 2011-2012
Age | Number | % Total |
---|---|---|
6 months-8 years | 1,490 | 31 |
9-17 years | 666 | 14 |
18-49 years | 1,549 | 32 |
50-64 years | 682 | 14 |
65+ years | 384 | 8 |
Gender | Number | % Total |
---|---|---|
Male | 2,417 | 51 |
Female | 2,354 | 49 |
On This Page
- Patients by Age
- Patients by Gender
- Patients by Race
- Influenza Virus Type And Subtype Among Influenza-Positive Patients
- Vaccine Effectiveness for all Vaccine Types Against influenza A or B viruses
- Vaccine Effectiveness for all Vaccine Types Against Influenza A (H3N2) viruses
- Influenza Vaccine Effectiveness by Virus Type and Subtype
Race | Number | % Total |
---|---|---|
White, non-Hispanic | 3,350 | 70 |
Black, non-Hispanic | 502 | 11 |
Hispanic | 425 | 9 |
Other, non-Hispanic | 494 | 10 |
- Page last reviewed: September 7, 2018
- Page last updated: September 7, 2018
- Content source:
- Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)
- Page maintained by: Office of the Associate Director for Communication, Digital Media Branch, Division of Public Affairs